AI Terminal
Sartorius AG
Post-Annual General Meeting Information • Mar 27, 2025
366_rns_2025-03-27_c71db18e-b1b1-4e4f-b211-68ecf972b3de.html
Post-Annual General Meeting Information
Open in ViewerOpens in native device viewer
News Details
Corporate | 27 March 2025 15:13
Sartorius AG – Resolutions of the Annual General Meeting
SARTORIUS AG / Key word(s): AGM/EGM/Dividend
Sartorius AG – Resolutions of the Annual General Meeting (news with additional features)
27.03.2025 / 15:13 CET/CEST
The issuer is solely responsible for the content of this announcement.
Göttingen, Germany | March 27, 2025
Sartorius AG – Resolutions of the Annual General Meeting
The life science group Sartorius held its virtual Annual General Meeting today. The shareholders approved all proposals of the Supervisory Board and the Executive Board by a large majority, including the dividend proposal of 0.74 euros per preference share and 0.73 euros per ordinary share. The total amount disbursed will be 50.7 million euros, with the dividend to be paid out to shareholders on April 1, 2025.
Further information
Website Annual General Meeting
CVs and images of Executive Board and Supervisory Board
Financial calendar
April 16, 2025 Publication of the first quarter results January to March 2025
July 22, 2025 Publication of the half-year results January to June 2025
October 16, 2025 Publication of the nine-month results January to September 2025
A profile of Sartorius
Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions Division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and sustainably. The company, based in Göttingen, Germany, has a strong global reach with around 60 production and sales sites worldwide. Sartorius regularly expands its portfolio through the acquisition of complementary technologies. In 2024, the company generated sales revenue of around 3.4 billion euros. Around 13,500 employees are working for customers around the globe.
Visit our Newsroom and follow Sartorius on LinkedIn .
Contact
Leona Malorny
Head of External Communications
+49 551 308 4067
Additional features:
File: Sartorius AG – Resolutions of the Annual General Meeting 2025 | Media Release
27.03.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | SARTORIUS AG |
| Otto-Brenner-Straße 20 | |
| 37079 Göttingen | |
| Germany | |
| Phone: | +49.(0)551-308.0 |
| Fax: | +49.(0)551-308.3289 |
| E-mail: | [email protected] |
| Internet: | www.sartorius.com |
| ISIN: | DE0007165631, DE0007165607 |
| WKN: | 716563, 716560 |
| Indices: | DAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2106876 |
| End of News | EQS News Service |
2106876 27.03.2025 CET/CEST